NM_020877.5:c.10169+3G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020877.5(DNAH2):​c.10169+3G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.344 in 1,613,956 control chromosomes in the GnomAD database, including 103,051 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6908 hom., cov: 31)
Exomes 𝑓: 0.35 ( 96143 hom. )

Consequence

DNAH2
NM_020877.5 splice_region, intron

Scores

2
Splicing: ADA: 0.00002793
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.05

Publications

17 publications found
Variant links:
Genes affected
DNAH2 (HGNC:2948): (dynein axonemal heavy chain 2) Dyneins are microtubule-associated motor protein complexes composed of several heavy, light, and intermediate chains. The axonemal dyneins, found in cilia and flagella, are components of the outer and inner dynein arms attached to the peripheral microtubule doublets. DNAH2 is an axonemal inner arm dynein heavy chain (Chapelin et al., 1997 [PubMed 9256245]).[supplied by OMIM, Mar 2008]
DNAH2 Gene-Disease associations (from GenCC):
  • spermatogenic failure 45
    Inheritance: AR Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 17-7817712-G-A is Benign according to our data. Variant chr17-7817712-G-A is described in ClinVar as Benign. ClinVar VariationId is 402712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.387 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH2NM_020877.5 linkc.10169+3G>A splice_region_variant, intron_variant Intron 66 of 85 ENST00000572933.6 NP_065928.2 Q9P225-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH2ENST00000572933.6 linkc.10169+3G>A splice_region_variant, intron_variant Intron 66 of 85 2 NM_020877.5 ENSP00000458355.1 Q9P225-1
DNAH2ENST00000389173.6 linkc.10169+3G>A splice_region_variant, intron_variant Intron 65 of 84 2 ENSP00000373825.2 Q9P225-1
DNAH2ENST00000575105.1 linkc.1016+3G>A splice_region_variant, intron_variant Intron 7 of 22 5 ENSP00000461726.1 I3L520

Frequencies

GnomAD3 genomes
AF:
0.277
AC:
42068
AN:
151970
Hom.:
6902
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.126
Gnomad AMI
AF:
0.378
Gnomad AMR
AF:
0.256
Gnomad ASJ
AF:
0.356
Gnomad EAS
AF:
0.0637
Gnomad SAS
AF:
0.159
Gnomad FIN
AF:
0.280
Gnomad MID
AF:
0.411
Gnomad NFE
AF:
0.391
Gnomad OTH
AF:
0.311
GnomAD2 exomes
AF:
0.280
AC:
70247
AN:
251192
AF XY:
0.286
show subpopulations
Gnomad AFR exome
AF:
0.116
Gnomad AMR exome
AF:
0.187
Gnomad ASJ exome
AF:
0.360
Gnomad EAS exome
AF:
0.0626
Gnomad FIN exome
AF:
0.286
Gnomad NFE exome
AF:
0.387
Gnomad OTH exome
AF:
0.326
GnomAD4 exome
AF:
0.351
AC:
512761
AN:
1461866
Hom.:
96143
Cov.:
86
AF XY:
0.347
AC XY:
252292
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.111
AC:
3715
AN:
33480
American (AMR)
AF:
0.193
AC:
8632
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.362
AC:
9469
AN:
26136
East Asian (EAS)
AF:
0.0681
AC:
2702
AN:
39700
South Asian (SAS)
AF:
0.163
AC:
14034
AN:
86258
European-Finnish (FIN)
AF:
0.285
AC:
15211
AN:
53410
Middle Eastern (MID)
AF:
0.370
AC:
2132
AN:
5768
European-Non Finnish (NFE)
AF:
0.393
AC:
436845
AN:
1111994
Other (OTH)
AF:
0.331
AC:
20021
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
22534
45068
67603
90137
112671
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13176
26352
39528
52704
65880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.277
AC:
42107
AN:
152090
Hom.:
6908
Cov.:
31
AF XY:
0.268
AC XY:
19939
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.126
AC:
5243
AN:
41530
American (AMR)
AF:
0.256
AC:
3910
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.356
AC:
1237
AN:
3472
East Asian (EAS)
AF:
0.0639
AC:
330
AN:
5166
South Asian (SAS)
AF:
0.160
AC:
769
AN:
4820
European-Finnish (FIN)
AF:
0.280
AC:
2957
AN:
10570
Middle Eastern (MID)
AF:
0.412
AC:
121
AN:
294
European-Non Finnish (NFE)
AF:
0.391
AC:
26543
AN:
67942
Other (OTH)
AF:
0.310
AC:
654
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1446
2891
4337
5782
7228
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
418
836
1254
1672
2090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.358
Hom.:
20865
Bravo
AF:
0.269
Asia WGS
AF:
0.124
AC:
430
AN:
3478
EpiCase
AF:
0.409
EpiControl
AF:
0.401

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

DNAH2-related disorder Benign:1
Oct 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.082
DANN
Benign
0.57
PhyloP100
-1.0
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000028
dbscSNV1_RF
Benign
0.036
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs872346; hg19: chr17-7721030; COSMIC: COSV66719233; API